Zydus Lifesciences gets FDA green light for acne treatment gel
Zydus Lifesciences Limited has secured final approval from the United States Food and Drug Administration (USFDA) for its Clindamycin Phosphate Gel USP, 1%. With annual sales of the acne treatment gel standing at a staggering USD 37 million in the U.S. (as of IQVIA MAT July 2023), the pharmaceutical giant is poised for significant market […]